WHO-Empfehlungen: Hepatitis C ließe sich eliminieren Dtsch Arztebl 2022; 119(38): A-1584 / B-1324 Lenzen-Schulte, Martina https://www.aerzteblatt.de/archiv/227616

Neuer Check-up für die Leber: Warum Hepatitis-Tests so sinnvoll sind Dtsch Arztebl 2022; 119(38): A-1590 / B-1322 Wolffram, Ingmar https://www.aerzteblatt.de/archiv/227644

Impact of an Accelerated Pretreatment Evaluation on Linkage-to-Care for Hepatitis C-infected Persons Who Inject Drugs.  Martel-Laferrière V, Brissette S, Wartelle-Bladou C, Juteau LC, Popa M, Goyer MÈ, Bruneau J.  Subst Abuse. 2022 Aug...

Direct-acting antiviral treatment uptake and sustained virological response outcomes are not affected by alcohol use: A CANUHC analysis.  Driedger M, Vachon ML, Wong A, Conway B, Ramji A, Borgia S, Tam E, Barrett L, Smyth D, Feld J...

Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness Analysis. McCombe G, Swan D, Lambert JS, O'Connor E, Ward Z, Vickerman P, Avramovic G, Crowley D, Ti...

Randomized clinical trial: Direct-acting antivirals as treatment for hepatitis C in people who inject drugs: Delivered in needle and syringe programs via directly observed therapy versus fortnightly collection. Beer, L, Inglis, S, Malag...